@article{e9bd9a4ee3dd473abc198b9df51f4d2c,
title = "Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017",
abstract = "OBJECTIVE: To assess the uptake of the OMERACT-OARSI (Outcome Measures in Rheumatology- Osteoarthritis Research Society International) core outcome set (COS) domains in hip and/or knee osteoarthritis (OA) trials.METHODS: There were 382 trials of hip and/or knee OA identified from the ClinicalTrial.gov registry from 1997 to 2017. Frequency of COS adoption was assessed by year and per 5-yearly phases.RESULTS: COS adoption decreased from 61% between 1997 and 2001 to 38% between 2012 and 2016. Pain (95%) and physical function (86%) were most consistently adopted. Patient's global assessment (48%) was the principal missing domain.CONCLUSION: Limited adoption of the COS domains indicates that further consideration to improve uptake is required.",
keywords = "Adoption, Core outcome set, Domain, OMERACT, Trial registration",
author = "Smith, {Toby O} and Michael Mansfield and Hawker, {Gillian A} and Hunter, {David J} and March, {Lyn M} and Maarten Boers and Shea, {Beverley J} and Robin Christensen and Francis Guillemin and Terwee, {Caroline B} and Williamson, {Paula R} and Roos, {Ewa M} and Loeser, {Richard F} and Schnitzer, {Thomas J} and Margreet Kloppenburg and Tuhina Neogi and Ladel, {Christoph H} and Gurdyal Kalsi and Ulrike Kaiser and Buttel, {Thomas W} and Ashford, {Anne E} and Ali Mobasheri and Arden, {Nigel K} and Alan Tennant and Hochberg, {Marc C} and {de Wit}, Maarten and Peter Tugwell and Conaghan, {Philip G}",
year = "2019",
month = aug,
doi = "10.3899/jrheum.181066",
language = "English",
volume = "46",
pages = "976--980",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "8",
}